2017
DOI: 10.12659/msm.903380
|View full text |Cite
|
Sign up to set email alerts
|

Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells

Abstract: BackgroundAltered expression of partition-defective 3 (PARD3), a polarity-related gene associated with oncogenesis, has been identified in some cancers, but the role of PARD3 in esophageal squamous cell carcinoma (ESCC) remains unclear.Material/MethodsPARD3 expression in Eca109 cells was silenced using siRNA and overexpressed using an expression vector. We investigated the role of PARD3 in ESCC growth and motility to evaluate its potential role in ESCC. Transwell assay was used to evaluated cell migration and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 30 publications
0
6
0
Order By: Relevance
“…CTNNA3 mediates cell adhesion (Janssens et al, 2001); when CTNNA3 was knocked down, CTNNA3-depleted cells showed abnormal skeleton (Stahn et al, 2016). In esophageal cancer, PARD3 overexpression promotes cell apoptosis, inhibits cell proliferation, and inhibits cell migration and invasion, whereas PARD3 silencing promotes cell proliferation and increases migration and invasion (Wang et al, 2017). PTPRM overexpression in small intestinal neuroendocrine tumor cell lines reduced cell growth and proliferation and induced apoptosis (Barazeghi et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…CTNNA3 mediates cell adhesion (Janssens et al, 2001); when CTNNA3 was knocked down, CTNNA3-depleted cells showed abnormal skeleton (Stahn et al, 2016). In esophageal cancer, PARD3 overexpression promotes cell apoptosis, inhibits cell proliferation, and inhibits cell migration and invasion, whereas PARD3 silencing promotes cell proliferation and increases migration and invasion (Wang et al, 2017). PTPRM overexpression in small intestinal neuroendocrine tumor cell lines reduced cell growth and proliferation and induced apoptosis (Barazeghi et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…A loss of Par3 can promote tumor metastasis in breast cancer (23). In summary, Par3 serves as a tumor promoter in radiationinduced retinal carcinoma (74) and ovarian cancer (75) and a tumor suppressor in most other cancer types, including breast cancer (23,76,77), thyroid cancer (78), lung cancer (79-81), glioma (82), esophageal cancer (83,84), endometrioid endometrial carcinoma (85), cervical cancer (86), and pancreatic cancer (87). Interestingly, research has also shown that Par3 has dual functions in skin cancer (88)(89)(90) and prostate cancer (73,91), with both pro-oncogenic and tumor-suppressive functions (90).…”
Section: Dual Function Of Par3 Proteinmentioning
confidence: 99%
“…Par3 is reduced or lost in a variety of cancer tissues including cervical cancer (86), lung adenocarcinoma (80), thyroid tumor (78), and human breast cancer tissues (77). In addition, the overexpression of Par3 results in the inhibition of the proliferation of esophageal cancer cells and intrauterine membrane carcinoma cells (83,85) as well as the promotion of tumor cell apoptosis (83). Furthermore, a loss of Par3 leads to active proliferation in many tumor cells (23,75,78,80,85,88).…”
Section: Par3 In Tumor Suppressionmentioning
confidence: 99%
“…However, despite advances have been made in recent years in the complete resections of ESCC, the prognosis of patients remains unsatisfactory due to the high incidence of local and distant failure. 4,5 Therefore, seeking a new direction for the treatment of ESCC is critical to improve patient prognosis.…”
Section: Introductionmentioning
confidence: 99%